Novartis CEO ‘very confident’ in his sales plans and not afraid of patent collapse

Novartis CEO Vas Narasimhan said in an interview on Saturday that he expects to increase its annual sales by at least 5 per cent a year in the coming years, with the pharma giant not having to fear the expiry of patent protection on some drugs.

Teile diesen Beitrag: